Epigenetic Research in Neuropsychiatric Disorders: the “Tissue Issue”
- 2 August 2016
- journal article
- research article
- Published by Springer Nature in Current Behavioral Neuroscience Reports
- Vol. 3 (3) , 264-274
Abstract
Purpose of Review Evidence has linked neuropsychiatric disorders with epigenetic marks as either a biomarker of disease, biomarker of exposure, or mechanism of disease processes. Neuropsychiatric epidemiologic studies using either target brain tissue or surrogate blood tissue each have methodological challenges and distinct advantages. Recent findings Brain tissue studies are challenged by small sample sizes of cases and controls, incomplete phenotyping, post-mortem timing, and cellular heterogeneity, but the use of a primary disease relevant tissue is critical. Blood-based studies have access to much larger sample sizes and more replication opportunities, as well as the potential for longitudinal measurements, both prior to onset and during the course of treatments. Yet, blood studies also are challenged by cell-type heterogeneity, and many question the validity of using peripheral tissues as a brain biomarker. Emerging evidence suggests that these limitations to blood-based epigenetic studies are surmountable, but confirmation in target tissue remains important. Summary Epigenetic mechanisms have the potential to help elucidate biology connecting experiential risk factors with neuropsychiatric disease manifestation. Cross-tissue studies as well as advanced epidemiologic methods should be employed to more effectively conduct neuropsychiatric epigenetic research.Keywords
Funding Information
- National Institute of Environmental Health Sciences (ES017646, ES023061)
- Medical Research Council (MRC; MR/K013807/1)
- National Institutes of Health (AG036039)
This publication has 109 references indexed in Scilit:
- Complex epigenetic regulation of Engrailed-2 (EN-2) homeobox gene in the autism cerebellumTranslational Psychiatry, 2013
- Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to diseaseInternational Journal of Epidemiology, 2012
- Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cellsNature Biotechnology, 2011
- Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cellsNature, 2011
- The NIH Roadmap Epigenomics Mapping ConsortiumNature Biotechnology, 2010
- Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: Unraveling the genome to understand the mindNeurobiology of Disease, 2010
- Environmental epigeneticsHeredity, 2010
- Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patternsHuman Molecular Genetics, 2009
- Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major PsychosisThe American Journal of Human Genetics, 2008
- Phenotypic plasticity and the epigenetics of human diseaseNature, 2007